The tissue-type plasminogen activator-plasminogen activator inhibitor 1 complex promotes neurovascular injury in brain trauma: evidence from mice and humans
about
Physiological and pathological roles of tissue plasminogen activator and its inhibitor neuroserpin in the nervous systemSubacute intranasal administration of tissue plasminogen activator promotes neuroplasticity and improves functional recovery following traumatic brain injury in ratsPharmacological targeting of the PDGF-CC signaling pathway for blood-brain barrier restoration in neurological disordersMultifaceted Mechanisms of WY-14643 to Stabilize the Blood-Brain Barrier in a Model of Traumatic Brain InjuryPlasmin-dependent modulation of the blood-brain barrier: a major consideration during tPA-induced thrombolysis?In vivo imaging of the neurovascular unit in CNS disease.TGF-β superfamily gene expression and induction of the Runx1 transcription factor in adult neurogenic regions after brain injury.Hypoxia-ischemia or excitotoxin-induced tissue plasminogen activator- dependent gelatinase activation in mice neonate brain microvessels.MiR-335 Regulates Hif-1α to Reduce Cell Death in Both Mouse Cell Line and Rat Ischemic Models.Hyperglycemia-suppressed expression of Serpine1 contributes to delayed epithelial wound healing in diabetic mouse corneas.The Influence of Differentially Expressed Tissue-Type Plasminogen Activator in Experimental Autoimmune Encephalomyelitis: Implications for Multiple Sclerosis.Imatinib treatment reduces brain injury in a murine model of traumatic brain injuryAblation of Type-1 IFN Signaling in Hematopoietic Cells Confers Protection Following Traumatic Brain InjuryMolecular contributions to neurovascular unit dysfunctions after brain injuries: lessons for target-specific drug development.Passenger mutations and aberrant gene expression in congenic tissue plasminogen activator-deficient mouse strains.Anti-lysophosphatidic acid antibodies improve traumatic brain injury outcomes.Major remodeling of brain microvessels during neonatal period in the mouse: A proteomic and transcriptomic study.Psychiatric disturbances regulate the innate immune system in CSF of conscious mice.tPA Modulation of the Blood-Brain Barrier: A Unifying Explanation for the Pleiotropic Effects of tPA in the CNS.Vascular inter-regulation of inflammation: molecular and cellular targets for CNS therapy.An ultra high performance liquid chromatography with tandem mass spectrometry method for plasma and cerebrospinal fluid pharmacokinetics of rhein in patients with traumatic brain injury after administration of rhubarb decoction.Editorial: The Role of the Plasminogen Activating System in Neurobiology.2-Methoxyestradiol confers neuroprotection and inhibits a maladaptive HIF-1α response after traumatic brain injury in mice.LDL receptor blockade reduces mortality in a mouse model of ischaemic stroke without improving tissue-type plasminogen activator-induced brain haemorrhage: towards pre-clinical simulation of symptomatic ICH.Extracellular matrix and traumatic brain injury.Fibrinolysis: from blood to the brain.Traumatic brain injury opens blood-brain barrier to stealth liposomes via an enhanced permeability and retention (EPR)-like effect.Protective Effects of Autologous Bone Marrow Mononuclear Cells After Administering t-PA in an Embolic Stroke Model.
P2860
Q26777276-FF390F2E-51A9-41F3-8684-C2F44290E3A8Q28542725-396C4712-CA64-4EF0-B934-6A7A30A78086Q29048615-58D227D6-ABF1-48D0-8257-1AC0795354D5Q33729415-3BFBA124-50DD-4AF1-AE43-FB4756842328Q34018715-E48E02A0-D560-41B6-83FF-2434A56F2910Q34138247-32DA6941-C9A9-436F-BB2F-737EAFBDABFBQ34650960-3B15E9A7-268C-447C-8E36-632273D54C5EQ34937315-65D188AC-1AD6-4DCB-9160-5D413FC0FA79Q35648315-D3F38549-B262-497D-B12D-A479ECA9AABCQ35678791-B7A9B80A-B946-4C41-8C71-4F7386026A5DQ36079853-AA1488FE-9001-4A09-8D81-3883BB661632Q36129940-25483152-06A8-4DFE-BD81-AAEDAA230F48Q36591218-2BEF1B69-8493-4647-A8B8-3911D7384A6DQ37523317-53EED5B6-DFD6-4DEE-B1CD-96E3AE575656Q37661804-80B1A61B-6F8A-4E99-81C6-F23735CAF38BQ37717276-0E454E9F-78D8-4904-8AD7-854696F1E2C4Q38395944-80EF7AFB-F845-4200-A159-5FF0258098B7Q38517137-09B3B105-B419-44CB-B42E-0CE7CA255DABQ38965982-987562D9-365A-4720-AB90-F76A24544428Q39031301-6A75D6AB-C513-4888-A7DD-8EC23521B23BQ41566211-0EA75442-B4E4-4347-A296-C7E65418EF4DQ42388151-53E78070-1078-4FF8-BF61-215DE7899901Q45177122-F5063066-7F3B-4B39-9383-63B98450F458Q47101474-7999EC01-0B08-4A83-B085-97FCDE53B824Q47854507-6D63839D-34BE-42E2-9FD0-274D727868FAQ48106697-FC3211B8-FD9C-41D1-B45D-FEE02CBAD340Q48126377-572B4C27-16E2-413A-802F-0EEEE3FBFA04Q48142151-113DE950-9971-45EE-896D-55E72D475753
P2860
The tissue-type plasminogen activator-plasminogen activator inhibitor 1 complex promotes neurovascular injury in brain trauma: evidence from mice and humans
description
2012 nî lūn-bûn
@nan
2012 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
The tissue-type plasminogen ac ...... evidence from mice and humans
@ast
The tissue-type plasminogen ac ...... evidence from mice and humans
@en
type
label
The tissue-type plasminogen ac ...... evidence from mice and humans
@ast
The tissue-type plasminogen ac ...... evidence from mice and humans
@en
prefLabel
The tissue-type plasminogen ac ...... evidence from mice and humans
@ast
The tissue-type plasminogen ac ...... evidence from mice and humans
@en
P2093
P2860
P50
P356
P1433
P1476
The tissue-type plasminogen ac ...... evidence from mice and humans
@en
P2093
Adam Galle
Elisa J Cops
Enming J Su
Eunice Sales
Jean-Dominique Vassalli
Jeffrey V Rosenfeld
Maria Daglas
Rime Madani
Robert L Medcalf
Roxann Freeman
P2860
P304
P356
10.1093/BRAIN/AWS178
P407
P50
P577
2012-07-20T00:00:00Z